Back to Search
Start Over
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
- Source :
- Arteriosclerosis, Thrombosis, and Vascular Biology. 24
- Publication Year :
- 2004
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2004.
-
Abstract
- Significant advances in our knowledge about interventions to prevent cardiovascular disease (CVD) have occurred since publication of the first female-specific recommendations for preventive cardiology in 1999.1 Despite research-based gains in the treatment of CVD, it remains the leading killer of women in the United States and in most developed areas of the world.2–3 In the United States alone, more than one half million women die of CVD each year, exceeding the number of deaths in men and the next 7 causes of death in women combined. This translates into approximately 1 death every minute.2 Coronary heart disease (CHD) accounts for the majority of CVD deaths in women, disproportionately afflicts racial and ethnic minorities, and is a prime target for prevention.1–2 Because CHD is often fatal, and because nearly two thirds of women who die suddenly have no previously recognized symptoms, it is essential to prevent CHD.2 Other forms of atherosclerotic/thrombotic CVD, such as cerebrovascular disease and peripheral arterial disease, are critically important in women. Strategies known to reduce the burden of CHD may have substantial benefits for the prevention of noncoronary atherosclerosis, although they have been studied less extensively in some of these settings. In the wake of the reports of the Women’s Health Initiative and the Heart and Estrogen/Progestin Replacement Study (HERS), which unexpectedly showed that combination hormone therapy was associated with adverse CVD effects, there is a heightened need to critically review and document strategies to prevent CVD in women.4–7 These studies underscore the importance of evidence-based practice for chronic disease prevention. Optimal translation and implementation of science to improve preventive care should include a rigorous process of evaluation and clear communication about the quantity and quality of evidence used to support clinical recommendations. Recently, there has been an increase in the …
- Subjects :
- medicine.medical_specialty
Evidence-based practice
medicine.medical_treatment
Alternative medicine
Ethnic group
Psychological intervention
Disease
Sex Factors
Physiology (medical)
medicine
Humans
Intensive care medicine
Evidence-Based Medicine
business.industry
Evidence-based medicine
Guideline
medicine.disease
Comorbidity
Surgery
Cardiovascular Diseases
Practice Guidelines as Topic
Women's Health
Smoking cessation
Female
Hormone therapy
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 15244636 and 10795642
- Volume :
- 24
- Database :
- OpenAIRE
- Journal :
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Accession number :
- edsair.doi.dedup.....88a6475d5bca7c715e1533b7db732cb0
- Full Text :
- https://doi.org/10.1161/01.atv.0000114834.85476.81